Selected publications
1. Lee PH, Fu H, Lai TC, Chiang CY, Chan CC, Lin HH*. Glycemic control and the risk of tuberculosis: a cohort study. PLOS Medicine. 2016 Aug; 13(8): e1002072.
2. Pan SC, Ku CC, Kao D, Ezzati M, Fang CT*, Lin HH*. Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study. Lancet Diabetes and Endocrinology. 2015 May; 3(5): 323-30.
3. Langley I, Lin HH*, Egwaga S, Doulla B, Ku CC, Murray M, Cohen T, Squire SB. Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach. Lancet Global health. 2014 Oct; 2(10):e581-91.
4. Lin HH*, Dowdy D, Dye C, Murray M, Cohen T. The impact of new tuberculosis diagnostics on transmission: why context matters. Bulletin of the World Health Organization. 2012 Oct; 90(10):739-747a.
5. Lin HH*, Ezzati M, Hsing-Yi Chang, Murray M. Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Am J Respir Crit Care Med. 2009 Sep; 180(5): 475-80.
6. Lin HH, Murray M, Cohen T, Colijn C, Ezzati M*. Effects of smoking and solid fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modeling study. Lancet. 2008 Oct; 372(9648): 1473-83.
All publications
-Journal articles
1. Lin HH, Ezzati M, Murray M*. Tobacco smoke, indoor air pollution and tuberculosis: A systematic review and meta-analysis. PLoS Med. 2007 Jan; 4(1): e20.
2. Lin HH, Murray M, Cohen T, Colijn C, Ezzati M*. Effects of smoking and solid fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modeling study. Lancet. 2008 Oct; 372(9648): 1473-83.
3. Lin HH*, Ezzati M, Hsing-Yi Chang, Murray M. Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Am J Respir Crit Care Med. 2009 Sep; 180(5): 475-80.
4. Ezzati M*, Lin HH. Health benefits of interventions to reduce greenhouse gases. [Correspondence] Lancet. 2010 Mar; 375(9717): 804.
5. Lin HH, Shin S, Blaya JA, Zhang Z, Cegielski P, Contreras C, Asencios L, Bonilla C, Bayona J, Paciorek CJ, Cohen T*. Assessing spatiotemporal patterns of multidrug-resistant and drug-sensitive tuberculosis in a South American setting. Epidemiol Infect. 2011 Nov; 139(11): 1784-93.
6. Lin HH. Future Prospect of New Tuberculosis Diagnostic Tools-View of Global Tuberculosis Prevention and Treatment. Journal of Antituberculosis. 2011 Mar: 2-4. (In Chinese)
7. Murray M*, Oxlade O, Lin HH. Modeling social, environmental and biological determinants of tuberculosis. Int J Tuberc Lung Dis. 2011 Jun; 15:S64–S70.
8. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011 Jul 2;378(9785):31-40. doi: 10.1016/S0140-6736(11)60679-X. Epub 2011 Jun 24. PMID: 21705069.
9. Lin HH, Langley I, Mwenda R, Doulla B, Egwaga S, Millington KA, Mann GH, Murray M, Squire SB, Cohen T*. A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools. Int J Tuberc Lung Dis. 2011 Aug; 15(8): 996-1004.
10. Baker M, Lin HH, Change HY, M Murray*. The risk of tuberculosis disease among people with diabetes, a prospective cohort study. Clin Infect Dis. 2012 Mar; 54(6): 818-825.
11. Manjourides J*, Lin HH, Shin S, Jeffery C, Contreras C, Cruz JS, Jave O, Yagui M, Asencios L, Pagano M, Cohen T. Identifying multidrug resistant tuberculosis transmission hotspots using routinely collected data. Tuberculosis. 2012 Mar; 92(3):273-9.
12. Lin HH, Shin SS, Contreras C, Asencios L, Paciorek CJ, Cohen T*. Use of Spatial Information to Predict Multidrug Resistance in Tuberculosis Patients, Peru. Emerg Infect Dis. 2012 May; 18(5):811-3.
13. Lee CH, Lee MC, Lin HH, Shu CC, Wang JY*, Lee LN, Chao KM. Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease. PLoS ONE. 2012 May; 7(5): e37978.
14. Langley I*, Doulla B, Lin HH, Millington K, Squire B. Modelling the impacts of new diagnostic tools for tuberculosis in developing countries to enhance policy decisions. Health Care Manag Sci. 2012 Sep; 15(3):239-53.
15. Lin HH*, Dowdy D, Dye C, Murray M, Cohen T. The impact of new tuberculosis diagnostics on transmission: why context matters. Bulletin of the World Health Organization. 2012 Oct; 90(10):739-747a.
16. Menzies NA, Cohen T, Lin HH, Murray M, Salomon JA*. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLoS Med.2012 Nov; 9(11):e1001347.
17. Dong YH, Lin HH, Shau WY, Wu YC, Chang CH*, Lai MS*. Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomized controlled trials. Thorax. 2013 Jan; 68(1):48-56.
18. Chen SW, Tsan YT, Chen JD, Hsieh HI, Lee CH, Lin HH, Wang JD, Chen PC*. Use of thiazolidinediones and risk of colorectal cancer in patients with diabetes: A nationwide population-based case-control study. Diabetes Care. 2013 Feb; 36(2):369-75.
19. Danaei G, Singh GM, Paciorek CJ, Lin JK, Cowan MJ, Finucane MM, et al. The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008. Circulation. 2013 Apr; 127(14):1493-502, 1502e1-8.
20. Lin CH, Wu RM, Chang HY, Chiang YT, Lin HH*. Preceding pain symptoms and Parkinson's disease: a nationwide population-based cohort study. Eur J Neurol. 2013 Oct; 20(10):1398-404.
21. Lin HH*, Chiang YT, Chuang JH, Yang SL, Chang HY, Ezzati M, Murray M. Exposure to secondhand smoke and risk of tuberculosis: prospective cohort study. PLoS One. 2013 Oct; 8(10):e77333.
22. Lee PH, Lin HC, Huang AS, Wei SH, Lai MS, Lin HH*. Diabetes and risk of tuberculosis relapse: nationwide nested case-control study. PLoS One. 2014 Mar; 9(3):e92623.
23. Ruan SY, Lin HH*, Huang CT, Kuo PH, Wu HD, Yu CJ. Exploring the heterogeneity of effects of corticosteroids on ARDS: a systematic review and meta-analysis. Critical Care. 2014 Apr; 18(2):R63.
24. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014 Aug; 2(8):634-47.
25. Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, Shackelford KA, Steiner C, Heuton KR, et al. Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014 Sep; 384(9947):980-1004.
26. Huang CT*, Lin HH, Ruan SY, Lee MS, Tsai YJ, Yu CJ. Efficacy and adverse events of high-frequency oscillatory ventilation in adult patients with acute respiratory distress syndrome: a meta-analysis. Critical care. 2014 May; 18(3):R102.
27. Lin HH, Suk CW, Lo HL, Huang RY, Enarson DA, Chiang CY*. Indoor air pollution from solid fuel and tuberculosis: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2014 May;18(5):613-21.
28. Murray CJ, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014 Sep; 384(9947):1005-70.
29. Lin HH, Chiang CY. What does systematic review and meta-analysis offer, and what does it not? Public Health Action.2014 Sep; 4(3):138.
30. Lin HH, Chang HY, Chiang YT, Wu MS, Lin JT, Liao WC*. Smoking, drinking, and pancreatitis: a population-based cohort study in Taiwan. Pancreas. 2014 Oct; 43(7):1117-22.
31. Langley I, Lin HH*, Egwaga S, Doulla B, Ku CC, Murray M, Cohen T, Squire SB. Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach. Lancet Global health. 2014 Oct; 2(10):e581-91.
32. Langley I*, Lin HH, Squire SB. Cost-effectiveness of Xpert MTB/RIF and investing in health care in Africa. [Correspondence] Lancet Global health. 2015 Feb; 3(2):e83-4.
33. Chiang CY, Bai KJ, Lin HH, Chien ST, Lee JJ, Enarson DA, Lee TI, Yu MC*, The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis, PLoS One. 2015 Mar; 10(3):e0121698.
34. Lee YJ, Chen JZ, Lin HC, Liu HY, Lin SY, Lin HH, Fang CT, Hsueh PR*, Impact of active screening for methicillin-resistant Staphylococcus aureus (MRSA) and decolonization on MRSA infections, mortality, and medical cost: a quasi-experimental study in surgical intensive care unit. Critical Care. 2015 Apr; 19(1):R143.
35. Pan SC, Ku CC, Kao D, Ezzati M, Fang CT*, Lin HH*. Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study. Lancet Diabetes Endocrinol. 2015 May; 3(5): 323-30.
36. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Jun; pii: S0140-6736(15)60692-4.
37. NCD Risk Factor Collaboration (NCD-RisC). Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants. Lancet Diabetes Endocrinol. 2015 Aug;3(8):624-37.
38. Lin MT, Lin HH, Lee PL, Weng PH, Lee CC, Lai TC, Liu W, Chen CL*. Beneficial effect of continuous positive airway pressure on lipid profiles in obstructive sleep apnea: a meta-analysis. Sleep and breathing. 2015 Sep; 19(3): 809-17.
39. Tseng E, Ho WC, Lin MH, Cheng TJ, Chen PC, Lin HH*. Chronic exposure to particulate matter and risk of cardiovascular mortality: cohort study from Taiwan. BMC Public Health. 2015 Sep; 15: 936.
40. Chen CC, Chiang CY, Pan SC, Wang JY, Lin HH*. Health system delay among patients with tuberculosis in Taiwan: 2003-2010. BMC infectious diseases. 2015 Oct; 15:491.
41. Lin HH, Wang L, Zhang H, Ruan Y, Chin DP, Dye C. Tuberculosis control in China: use of modelling to develop targets and policies. Bulletin of the World Health Organization. 2015 Nov. 93(11):790-798.
42. Pan SC, Chen YC, Wang JY, Sheng WH, Lin HH, Fang CT, Chang SC. Tuberculosis in Healthcare Workers: A Matched Cohort Study in Taiwan. PLoS One. 2015 Dec; 10(12): e0145047.
43. Lai TC, Chiang CY, Wu CF, Yang SL, Liu DP, Chan CC, Lin HH*. Ambient air pollution and risk of tuberculosis: a cohort study. Occupational and Environmental Medicine. 2016 Jan;73(1):56-61.
44. Lo WC, Shie RH, Chan CC*, Lin HH*. Burden of disease attributable to ambient fine particulate matter exposure in Taiwan. Journal of Formosan Medical Association. 2016 Feb; pii: S0929-6646(15)00414-3.
45. Pan SC, Chen CC, Chiang YT, Chang HY, Fang CT, Lin HH*. Health care visits as a risk factor for tuberculosis in Taiwan: a population-based case-control study. American Journal of Public Health. 2016 July; 106(7): 1323-28.
46. Lin YH, Lin HH, Liu HM, Lee CW, Chen YF. Diagnostic performance of CT and MRI on the detection of symptomatic intracranial dural arteriovenous fistula: a meta-analysis with indirect comparison. Neuroradiology. 2016 Aug;58(8):753-63. doi: 10.1007/s00234-016-1696-8. Epub 2016 May 16. PMID: 27185610.
47. Shu CC, Hsu CL, Wei YF, Lee CY, Liou HH, Wu VC, Yang FJ, Lin HH, Wang JY, Chen JS, Yu CJ, Lee LN. Risk of Tuberculosis Among Patients on Dialysis: The Predictive Value of Serial Interferon-Gamma Release Assay. Medicine (Baltimore). 2016 May;95(22):e3813. doi: 10.1097/MD.0000000000003813. PMID: 27258523; PMCID: PMC4900731.
48. NCD Risk Factor Collaboration (NCD-RisC). A century of trends in adult human height. Elife. 2016 Jul 26;5:e13410. doi: 10.7554/eLife.13410. PMID: 27458798; PMCID: PMC4961475.
49. Lee PH, Fu H, Lai TC, Chiang CY, Chan CC, Lin HH*. Glycemic control and the risk of tuberculosis: a cohort study. PLOS Medicine. 2016 Aug; 13(8): e1002072
50. Houben RM, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, et al. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. Lancet Global Health 2016 Nov; 4(11):e806–e815.
51. Menzies NA, Gomez GB, Bozzani F, Chatterjee S, Foster N, Baena IG, et al. Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. The Lancet Global Health, 2016 Nov; 4(11):e816-e826.
52. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017 Jan 7;389(10064):37-55. doi: 10.1016/S0140-6736(16)31919-5. Epub 2016 Nov 16. Erratum in: Lancet. 2020 Sep 26;396(10255):886. PMID: 27863813; PMCID: PMC5220163.
53. Ruan SY, Wu HY, Lin HH, Wu HD, Yu CJ, Lai MS. Inhaled nitric oxide and the risk of renal dysfunction in patients with acute respiratory distress syndrome: a propensity-matched cohort study. 2016 Nov. Critical Care. 20(1), 389.
54. Lee MR, Huang YP, Kuo YT, Luo CH, Shih YJ, Shu CC, Wang JY, Ko JC, Yu CJ, Lin HH*. Diabetes mellitus and latent tuberculosis infection: a systemic review and meta-analysis. Clinical Infectious Diseases. 2017 Mar 15;64(6):719-727. doi: 10.1093/cid/ciw836.
55. Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. The Lancet Respiratory Medicine. 2017 Mar. 5(4): 291-360.
56. Van Wyk SS, Lin HH, Claassens MM*. A systematic review of prediction models for prevalent pulmonary tuberculosis in adults. The International Journal of Tuberculosis and Lung Disease. 2017 Apr. 21(4): 405-411.
57. Lo WC, Ku CC, Chiou ST, Chan CC, Chen CL, Lai MS, Lin HH*. Adult mortality of diseases and injuries attributable to metabolic, lifestyle, environmental, and infectious risk factors in Taiwan: a comparative risk assessment. Population Health Metrics. 2017 May 3; 15(1), 17. doi: 10.1186/s12963-017-0134-4.
58. 吳昀麇、呂宗學、林先和*.全球疾病負擔研究中的健康照護品質排名—以慢性腎臟病為例.台灣衛誌. 36(4):315-318. 2017 Aug.
59. Wu MY, Chen TT, Chen YC, Tarng DC, Wu YC, Lin HH, Tu YK. Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis. PLoS One. 2017 Sep 12;12(9):e0184380. doi: 10.1371/journal.pone.0184380. Erratum in: PLoS One. 2019 Apr 11;14(4):e0215624. PMID: 28898297; PMCID: PMC5595312.
60. Lin HH*, Wu CY, Wang CH, Fu H, Lonnroth K, Chang YC, Huang YT. Association of obesity, diabetes, and risk of tuberculosis: two population-based cohorts. Clinical Infectious Diseases, 2018 Mar 1; 66(5): 699–705.
61. Withers M*, Li M, Manalo G, So S, Wipfli H, Khoo HE, Khoo HE, Wu TS, Lin HH. Best Practices in Global Health Practicums: Recommendations from the Association of Pacific Rim Universities. Journal of community health, 1-10. 2017 Nov. doi: 10.1007/s10900-017-0439-z.
62. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128· 9 million children, adolescents, and adults. Lancet. 2017 Dec. 390(10113):2627-2642.
63. Lee PH, Fu H, Lee MR, Magee M, Lin HH. Tuberculosis and diabetes in low and moderate tuberculosis incidence countries. International Journal of Tuberculosis and Lung Disease. 2018 Jan; 22(1):7-16.
64. Onyoh E, Kuaban C, Lin HH*. Pre-treatment loss to follow-up of pulmonary tuberculosis patients in two regions of Cameroon. The International Journal of Tuberculosis and Lung Disease. 2018 Apr 1;22(4):378-384. doi: 10.5588/ijtld.17.0676.
65. NCD Risk Factor Collaboration (NCD-RisC). Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants. Int J Epidemiol. 2018 Jun 1;47(3):872-883i. doi: 10.1093/ije/dyy016. PMID: 29579276; PMCID: PMC6005056.
66. Fu H, Lin HH, Hallett TB, Arinaminpathy N. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting. Vaccine. 2018 Sep, 36;39: 5902-5909.
67. Cho P, Wu CY, Johnston J, Wu MY, Shu CC, Lin HH. Progression of chronic kidney disease and the risk of tuberculosis: an observational cohort study. The International Journal of Tuberculosis and Lung Disease. 2019 May; 23(5), 555-562.
68. Bao J, Hafner R, Lin Y, Lin HH, Magee MJ. Curbing the tuberculosis and diabetes co-epidemic: strategies for the integration of clinical care and research. Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1111-1112. doi: 10.5588/ijtld.18.0482.
69. Withers M, Lin HH, Schmidt T, Delos Trinos JPCR, Kumar S. Establishing Competencies for a Global Health Workforce: Recommendations from the Association of Pacific Rim Universities. Ann Glob Health. 2019 Mar 26;85(1). pii: 47. doi: 10.5334/aogh.32.
70. Wu MY, Chen TT, Chen YC, Tarng DC, Wu YC, Lin HH, Tu YK. Correction: Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis. PLoS One. 2019 Apr 11;14(4):e0215624. doi: 10.1371/journal.pone.0215624.
71. Shih YJ, Ayles H, Lönnroth K, Claassens M, Lin HH. Development and validation of a prediction model for active tuberculosis case finding among HIV-negative/unknown populations. Sci Rep. 2019 Apr 16;9(1):6143. doi: 10.1038/s41598-019-42372-x.
72. NCD Risk Factor Collaboration (NCD-RisC). Rising rural body-mass index is the main driver of the global obesity epidemic in adults. Nature. 2019 May; 569(7755):260-264. doi: 10.1038/s41586-019-1171-x.
73. Salindri AD, Wang JY, Lin HH, Magee MJ. Post-tuberculosis incidence of diabetes, myocardial infarction, and stroke: Retrospective cohort analysis of patients formerly treated for tuberculosis in Taiwan, 2002-2013. Int J Infect Dis. 2019 Jul;84:127-130. doi: 10.1016/j.ijid.2019.05.015.
74. Chio CP, Lo WC, Tsuang BJ, Hu CC, Ku KC, Chen YJ, Lin HH, Chan CC. Health impact assessment of PM2.5 from a planned coal-fired power plant in Taiwan. J Formos Med Assoc. 2019 Nov;118(11):1494-1503. doi: 10.1016/j.jfma.2019.08.016. Epub 2019 Sep 5. PMID: 31495542.
75. Chang CC, Wang JL, Wu LC, Chuang LM, Lin HH. Diabetes, Glycemic Control, and Risk of Infection Morbidity and Mortality: A Cohort Study. Open Forum Infectious Diseases. 2019 Oct; Volume 6, Issue 10, ofz358, https://doi.org/10.1093/ofid/ofz358
76. Ng TC, Lo WC, Ku CC, Lu TH, & Lin HH. Improving the use of mortality data in public health: A comparison of garbage code redistribution models. American journal of public health.2020; 110(2), 222-229.
77. Shu CC, Wei YF, Yeh YC, Lin HH, Chen CY, Wang PH, Cheng SL, Wang JY, Yu CJ. The impact on incident tuberculosis by kidney function impairment status: analysis of severity relationship. Respir Res. 2020 Feb 12;21(1):51. doi: 10.1186/s12931-020-1294-5. PMID: 32050967; PMCID: PMC7017479.
78. Fu H, Lin HH, Hallett TB, Arinaminpathy N. Explaining age disparities in tuberculosis burden in Taiwan: a modelling study. BMC Infect Dis. 2020 Mar 4;20(1):191. doi: 10.1186/s12879-020-4914-2. PMID: 32131756; PMCID: PMC7057673.
79. Cheng HY, Jian SW, Liu DP, Ng TC, Huang WT, Lin HH. Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset. JAMA Internal Medicine. 2020;180(9):1156-1163. doi:10.1001/jamainternmed.2020.2020
80. NCD Risk Factor Collaboration (NCD-RisC). Repositioning of the global epicentre of non-optimal cholesterol. Nature. 2020 Jun;582(7810):73-77. doi: 10.1038/s41586-020-2338-1. Epub 2020 Jun 3. PMID: 32494083; PMCID: PMC7332422.
81. Ku CC, Chen CC, Dixon S, Lin HH, Dodd PJ. Patient pathways of tuberculosis care-seeking and treatment: an individual-level analysis of National Health Insurance data in Taiwan. BMJ Glob Health. 2020 Jun;5(6):e002187. doi: 10.1136/bmjgh-2019-002187. PMID: 32565426; PMCID: PMC7307534.
82. NCD Risk Factor Collaboration (NCD-RisC). Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants. Lancet. 2020 Nov 7;396(10261):1511-1524. doi: 10.1016/S0140-6736(20)31859-6. PMID: 33160572; PMCID: PMC7658740.
83. Wu YC, Lo WC, Lu TH, Chang SS, Lin HH, Chan CC. Mortality, morbidity, and risk factors in Taiwan, 1990-2017: findings from the Global Burden of Disease Study 2017. J Formos Med Assoc. 2021 Jun;120(6):1340-1349. doi: 10.1016/j.jfma.2020.11.014. Epub 2020 Dec 10. PMID: 33309080.
84. Yang WS, Chang YC, Chang CH, Wu LC, Wang JL, Lin HH. The Association between Body Mass Index and the Risk of Hospitalization and Mortality due to Infection: a prospective cohort study. Open Forum Infectious Diseases. Oct, 2020. Volume 8, Issue 1, ofaa545, https://doi.org/10.1093/ofid/ofaa545
85. NCD Risk Factor Collaboration (NCD-RisC). Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight. Elife. 2021 Mar 9;10:e60060. doi: 10.7554/eLife.60060. PMID: 33685583; PMCID: PMC7943191.
86. Shen BJ, Lo WC, Lin HH. Global burden of tuberculosis attributable to cancer in 2019: Global, regional, and national estimates. J Microbiol Immunol Infect. 2021 Mar 8:S1684-1182(21)00048-7. doi: 10.1016/j.jmii.2021.02.005. Epub ahead of print. PMID: 33789827.
87. Cheng HY, Cohen T, Lin HH. Test, trace, and isolate in the UK. BMJ. 2021 Mar 31;372:n822. doi: 10.1136/bmj.n822. PMID: 33789886.
88. Ng TC, Cheng HY, Chang HH, Liu CC, Yang CC, Jian SW, Liu DP, Cohen T, Lin HH. Comparison of Estimated Effectiveness of Case-Based and Population-Based Interventions on COVID-19 Containment in Taiwan. JAMA Intern Med. Published online April 06, 2021. doi:10.1001/jamainternmed.2021.1644
89. Summers J, Cheng HY, Lin HH, Barnard LT, Kvalsvig A, Wilson N, Baker MG. Potential lessons from the Taiwan and New Zealand health responses to the COVID-19 pandemic. Lancet Reg Health West Pac. 2020 Nov;4:100044. doi: 10.1016/j.lanwpc.2020.100044. Epub 2020 Oct 21. PMID: 34013216; PMCID: PMC7577184.
90. Shen BJ, Lin HH. Time-dependent association between cancer and risk of tuberculosis: A population-based cohort study. Int J Infect Dis. 2021 Jul;108:340-346. doi: 10.1016/j.ijid.2021.05.037. Epub 2021 May 19. PMID: 34022337.
2. Lin HH, Murray M, Cohen T, Colijn C, Ezzati M*. Effects of smoking and solid fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modeling study. Lancet. 2008 Oct; 372(9648): 1473-83.
3. Lin HH*, Ezzati M, Hsing-Yi Chang, Murray M. Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Am J Respir Crit Care Med. 2009 Sep; 180(5): 475-80.
4. Ezzati M*, Lin HH. Health benefits of interventions to reduce greenhouse gases. [Correspondence] Lancet. 2010 Mar; 375(9717): 804.
5. Lin HH, Shin S, Blaya JA, Zhang Z, Cegielski P, Contreras C, Asencios L, Bonilla C, Bayona J, Paciorek CJ, Cohen T*. Assessing spatiotemporal patterns of multidrug-resistant and drug-sensitive tuberculosis in a South American setting. Epidemiol Infect. 2011 Nov; 139(11): 1784-93.
6. Lin HH. Future Prospect of New Tuberculosis Diagnostic Tools-View of Global Tuberculosis Prevention and Treatment. Journal of Antituberculosis. 2011 Mar: 2-4. (In Chinese)
7. Murray M*, Oxlade O, Lin HH. Modeling social, environmental and biological determinants of tuberculosis. Int J Tuberc Lung Dis. 2011 Jun; 15:S64–S70.
8. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011 Jul 2;378(9785):31-40. doi: 10.1016/S0140-6736(11)60679-X. Epub 2011 Jun 24. PMID: 21705069.
9. Lin HH, Langley I, Mwenda R, Doulla B, Egwaga S, Millington KA, Mann GH, Murray M, Squire SB, Cohen T*. A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools. Int J Tuberc Lung Dis. 2011 Aug; 15(8): 996-1004.
10. Baker M, Lin HH, Change HY, M Murray*. The risk of tuberculosis disease among people with diabetes, a prospective cohort study. Clin Infect Dis. 2012 Mar; 54(6): 818-825.
11. Manjourides J*, Lin HH, Shin S, Jeffery C, Contreras C, Cruz JS, Jave O, Yagui M, Asencios L, Pagano M, Cohen T. Identifying multidrug resistant tuberculosis transmission hotspots using routinely collected data. Tuberculosis. 2012 Mar; 92(3):273-9.
12. Lin HH, Shin SS, Contreras C, Asencios L, Paciorek CJ, Cohen T*. Use of Spatial Information to Predict Multidrug Resistance in Tuberculosis Patients, Peru. Emerg Infect Dis. 2012 May; 18(5):811-3.
13. Lee CH, Lee MC, Lin HH, Shu CC, Wang JY*, Lee LN, Chao KM. Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease. PLoS ONE. 2012 May; 7(5): e37978.
14. Langley I*, Doulla B, Lin HH, Millington K, Squire B. Modelling the impacts of new diagnostic tools for tuberculosis in developing countries to enhance policy decisions. Health Care Manag Sci. 2012 Sep; 15(3):239-53.
15. Lin HH*, Dowdy D, Dye C, Murray M, Cohen T. The impact of new tuberculosis diagnostics on transmission: why context matters. Bulletin of the World Health Organization. 2012 Oct; 90(10):739-747a.
16. Menzies NA, Cohen T, Lin HH, Murray M, Salomon JA*. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLoS Med.2012 Nov; 9(11):e1001347.
17. Dong YH, Lin HH, Shau WY, Wu YC, Chang CH*, Lai MS*. Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomized controlled trials. Thorax. 2013 Jan; 68(1):48-56.
18. Chen SW, Tsan YT, Chen JD, Hsieh HI, Lee CH, Lin HH, Wang JD, Chen PC*. Use of thiazolidinediones and risk of colorectal cancer in patients with diabetes: A nationwide population-based case-control study. Diabetes Care. 2013 Feb; 36(2):369-75.
19. Danaei G, Singh GM, Paciorek CJ, Lin JK, Cowan MJ, Finucane MM, et al. The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008. Circulation. 2013 Apr; 127(14):1493-502, 1502e1-8.
20. Lin CH, Wu RM, Chang HY, Chiang YT, Lin HH*. Preceding pain symptoms and Parkinson's disease: a nationwide population-based cohort study. Eur J Neurol. 2013 Oct; 20(10):1398-404.
21. Lin HH*, Chiang YT, Chuang JH, Yang SL, Chang HY, Ezzati M, Murray M. Exposure to secondhand smoke and risk of tuberculosis: prospective cohort study. PLoS One. 2013 Oct; 8(10):e77333.
22. Lee PH, Lin HC, Huang AS, Wei SH, Lai MS, Lin HH*. Diabetes and risk of tuberculosis relapse: nationwide nested case-control study. PLoS One. 2014 Mar; 9(3):e92623.
23. Ruan SY, Lin HH*, Huang CT, Kuo PH, Wu HD, Yu CJ. Exploring the heterogeneity of effects of corticosteroids on ARDS: a systematic review and meta-analysis. Critical Care. 2014 Apr; 18(2):R63.
24. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol. 2014 Aug; 2(8):634-47.
25. Kassebaum NJ, Bertozzi-Villa A, Coggeshall MS, Shackelford KA, Steiner C, Heuton KR, et al. Global, regional, and national levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014 Sep; 384(9947):980-1004.
26. Huang CT*, Lin HH, Ruan SY, Lee MS, Tsai YJ, Yu CJ. Efficacy and adverse events of high-frequency oscillatory ventilation in adult patients with acute respiratory distress syndrome: a meta-analysis. Critical care. 2014 May; 18(3):R102.
27. Lin HH, Suk CW, Lo HL, Huang RY, Enarson DA, Chiang CY*. Indoor air pollution from solid fuel and tuberculosis: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2014 May;18(5):613-21.
28. Murray CJ, Ortblad KF, Guinovart C, Lim SS, Wolock TM, Roberts DA, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014 Sep; 384(9947):1005-70.
29. Lin HH, Chiang CY. What does systematic review and meta-analysis offer, and what does it not? Public Health Action.2014 Sep; 4(3):138.
30. Lin HH, Chang HY, Chiang YT, Wu MS, Lin JT, Liao WC*. Smoking, drinking, and pancreatitis: a population-based cohort study in Taiwan. Pancreas. 2014 Oct; 43(7):1117-22.
31. Langley I, Lin HH*, Egwaga S, Doulla B, Ku CC, Murray M, Cohen T, Squire SB. Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach. Lancet Global health. 2014 Oct; 2(10):e581-91.
32. Langley I*, Lin HH, Squire SB. Cost-effectiveness of Xpert MTB/RIF and investing in health care in Africa. [Correspondence] Lancet Global health. 2015 Feb; 3(2):e83-4.
33. Chiang CY, Bai KJ, Lin HH, Chien ST, Lee JJ, Enarson DA, Lee TI, Yu MC*, The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis, PLoS One. 2015 Mar; 10(3):e0121698.
34. Lee YJ, Chen JZ, Lin HC, Liu HY, Lin SY, Lin HH, Fang CT, Hsueh PR*, Impact of active screening for methicillin-resistant Staphylococcus aureus (MRSA) and decolonization on MRSA infections, mortality, and medical cost: a quasi-experimental study in surgical intensive care unit. Critical Care. 2015 Apr; 19(1):R143.
35. Pan SC, Ku CC, Kao D, Ezzati M, Fang CT*, Lin HH*. Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study. Lancet Diabetes Endocrinol. 2015 May; 3(5): 323-30.
36. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Jun; pii: S0140-6736(15)60692-4.
37. NCD Risk Factor Collaboration (NCD-RisC). Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants. Lancet Diabetes Endocrinol. 2015 Aug;3(8):624-37.
38. Lin MT, Lin HH, Lee PL, Weng PH, Lee CC, Lai TC, Liu W, Chen CL*. Beneficial effect of continuous positive airway pressure on lipid profiles in obstructive sleep apnea: a meta-analysis. Sleep and breathing. 2015 Sep; 19(3): 809-17.
39. Tseng E, Ho WC, Lin MH, Cheng TJ, Chen PC, Lin HH*. Chronic exposure to particulate matter and risk of cardiovascular mortality: cohort study from Taiwan. BMC Public Health. 2015 Sep; 15: 936.
40. Chen CC, Chiang CY, Pan SC, Wang JY, Lin HH*. Health system delay among patients with tuberculosis in Taiwan: 2003-2010. BMC infectious diseases. 2015 Oct; 15:491.
41. Lin HH, Wang L, Zhang H, Ruan Y, Chin DP, Dye C. Tuberculosis control in China: use of modelling to develop targets and policies. Bulletin of the World Health Organization. 2015 Nov. 93(11):790-798.
42. Pan SC, Chen YC, Wang JY, Sheng WH, Lin HH, Fang CT, Chang SC. Tuberculosis in Healthcare Workers: A Matched Cohort Study in Taiwan. PLoS One. 2015 Dec; 10(12): e0145047.
43. Lai TC, Chiang CY, Wu CF, Yang SL, Liu DP, Chan CC, Lin HH*. Ambient air pollution and risk of tuberculosis: a cohort study. Occupational and Environmental Medicine. 2016 Jan;73(1):56-61.
44. Lo WC, Shie RH, Chan CC*, Lin HH*. Burden of disease attributable to ambient fine particulate matter exposure in Taiwan. Journal of Formosan Medical Association. 2016 Feb; pii: S0929-6646(15)00414-3.
45. Pan SC, Chen CC, Chiang YT, Chang HY, Fang CT, Lin HH*. Health care visits as a risk factor for tuberculosis in Taiwan: a population-based case-control study. American Journal of Public Health. 2016 July; 106(7): 1323-28.
46. Lin YH, Lin HH, Liu HM, Lee CW, Chen YF. Diagnostic performance of CT and MRI on the detection of symptomatic intracranial dural arteriovenous fistula: a meta-analysis with indirect comparison. Neuroradiology. 2016 Aug;58(8):753-63. doi: 10.1007/s00234-016-1696-8. Epub 2016 May 16. PMID: 27185610.
47. Shu CC, Hsu CL, Wei YF, Lee CY, Liou HH, Wu VC, Yang FJ, Lin HH, Wang JY, Chen JS, Yu CJ, Lee LN. Risk of Tuberculosis Among Patients on Dialysis: The Predictive Value of Serial Interferon-Gamma Release Assay. Medicine (Baltimore). 2016 May;95(22):e3813. doi: 10.1097/MD.0000000000003813. PMID: 27258523; PMCID: PMC4900731.
48. NCD Risk Factor Collaboration (NCD-RisC). A century of trends in adult human height. Elife. 2016 Jul 26;5:e13410. doi: 10.7554/eLife.13410. PMID: 27458798; PMCID: PMC4961475.
49. Lee PH, Fu H, Lai TC, Chiang CY, Chan CC, Lin HH*. Glycemic control and the risk of tuberculosis: a cohort study. PLOS Medicine. 2016 Aug; 13(8): e1002072
50. Houben RM, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, et al. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. Lancet Global Health 2016 Nov; 4(11):e806–e815.
51. Menzies NA, Gomez GB, Bozzani F, Chatterjee S, Foster N, Baena IG, et al. Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. The Lancet Global Health, 2016 Nov; 4(11):e816-e826.
52. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2017 Jan 7;389(10064):37-55. doi: 10.1016/S0140-6736(16)31919-5. Epub 2016 Nov 16. Erratum in: Lancet. 2020 Sep 26;396(10255):886. PMID: 27863813; PMCID: PMC5220163.
53. Ruan SY, Wu HY, Lin HH, Wu HD, Yu CJ, Lai MS. Inhaled nitric oxide and the risk of renal dysfunction in patients with acute respiratory distress syndrome: a propensity-matched cohort study. 2016 Nov. Critical Care. 20(1), 389.
54. Lee MR, Huang YP, Kuo YT, Luo CH, Shih YJ, Shu CC, Wang JY, Ko JC, Yu CJ, Lin HH*. Diabetes mellitus and latent tuberculosis infection: a systemic review and meta-analysis. Clinical Infectious Diseases. 2017 Mar 15;64(6):719-727. doi: 10.1093/cid/ciw836.
55. Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. The Lancet Respiratory Medicine. 2017 Mar. 5(4): 291-360.
56. Van Wyk SS, Lin HH, Claassens MM*. A systematic review of prediction models for prevalent pulmonary tuberculosis in adults. The International Journal of Tuberculosis and Lung Disease. 2017 Apr. 21(4): 405-411.
57. Lo WC, Ku CC, Chiou ST, Chan CC, Chen CL, Lai MS, Lin HH*. Adult mortality of diseases and injuries attributable to metabolic, lifestyle, environmental, and infectious risk factors in Taiwan: a comparative risk assessment. Population Health Metrics. 2017 May 3; 15(1), 17. doi: 10.1186/s12963-017-0134-4.
58. 吳昀麇、呂宗學、林先和*.全球疾病負擔研究中的健康照護品質排名—以慢性腎臟病為例.台灣衛誌. 36(4):315-318. 2017 Aug.
59. Wu MY, Chen TT, Chen YC, Tarng DC, Wu YC, Lin HH, Tu YK. Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis. PLoS One. 2017 Sep 12;12(9):e0184380. doi: 10.1371/journal.pone.0184380. Erratum in: PLoS One. 2019 Apr 11;14(4):e0215624. PMID: 28898297; PMCID: PMC5595312.
60. Lin HH*, Wu CY, Wang CH, Fu H, Lonnroth K, Chang YC, Huang YT. Association of obesity, diabetes, and risk of tuberculosis: two population-based cohorts. Clinical Infectious Diseases, 2018 Mar 1; 66(5): 699–705.
61. Withers M*, Li M, Manalo G, So S, Wipfli H, Khoo HE, Khoo HE, Wu TS, Lin HH. Best Practices in Global Health Practicums: Recommendations from the Association of Pacific Rim Universities. Journal of community health, 1-10. 2017 Nov. doi: 10.1007/s10900-017-0439-z.
62. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128· 9 million children, adolescents, and adults. Lancet. 2017 Dec. 390(10113):2627-2642.
63. Lee PH, Fu H, Lee MR, Magee M, Lin HH. Tuberculosis and diabetes in low and moderate tuberculosis incidence countries. International Journal of Tuberculosis and Lung Disease. 2018 Jan; 22(1):7-16.
64. Onyoh E, Kuaban C, Lin HH*. Pre-treatment loss to follow-up of pulmonary tuberculosis patients in two regions of Cameroon. The International Journal of Tuberculosis and Lung Disease. 2018 Apr 1;22(4):378-384. doi: 10.5588/ijtld.17.0676.
65. NCD Risk Factor Collaboration (NCD-RisC). Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants. Int J Epidemiol. 2018 Jun 1;47(3):872-883i. doi: 10.1093/ije/dyy016. PMID: 29579276; PMCID: PMC6005056.
66. Fu H, Lin HH, Hallett TB, Arinaminpathy N. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting. Vaccine. 2018 Sep, 36;39: 5902-5909.
67. Cho P, Wu CY, Johnston J, Wu MY, Shu CC, Lin HH. Progression of chronic kidney disease and the risk of tuberculosis: an observational cohort study. The International Journal of Tuberculosis and Lung Disease. 2019 May; 23(5), 555-562.
68. Bao J, Hafner R, Lin Y, Lin HH, Magee MJ. Curbing the tuberculosis and diabetes co-epidemic: strategies for the integration of clinical care and research. Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1111-1112. doi: 10.5588/ijtld.18.0482.
69. Withers M, Lin HH, Schmidt T, Delos Trinos JPCR, Kumar S. Establishing Competencies for a Global Health Workforce: Recommendations from the Association of Pacific Rim Universities. Ann Glob Health. 2019 Mar 26;85(1). pii: 47. doi: 10.5334/aogh.32.
70. Wu MY, Chen TT, Chen YC, Tarng DC, Wu YC, Lin HH, Tu YK. Correction: Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis. PLoS One. 2019 Apr 11;14(4):e0215624. doi: 10.1371/journal.pone.0215624.
71. Shih YJ, Ayles H, Lönnroth K, Claassens M, Lin HH. Development and validation of a prediction model for active tuberculosis case finding among HIV-negative/unknown populations. Sci Rep. 2019 Apr 16;9(1):6143. doi: 10.1038/s41598-019-42372-x.
72. NCD Risk Factor Collaboration (NCD-RisC). Rising rural body-mass index is the main driver of the global obesity epidemic in adults. Nature. 2019 May; 569(7755):260-264. doi: 10.1038/s41586-019-1171-x.
73. Salindri AD, Wang JY, Lin HH, Magee MJ. Post-tuberculosis incidence of diabetes, myocardial infarction, and stroke: Retrospective cohort analysis of patients formerly treated for tuberculosis in Taiwan, 2002-2013. Int J Infect Dis. 2019 Jul;84:127-130. doi: 10.1016/j.ijid.2019.05.015.
74. Chio CP, Lo WC, Tsuang BJ, Hu CC, Ku KC, Chen YJ, Lin HH, Chan CC. Health impact assessment of PM2.5 from a planned coal-fired power plant in Taiwan. J Formos Med Assoc. 2019 Nov;118(11):1494-1503. doi: 10.1016/j.jfma.2019.08.016. Epub 2019 Sep 5. PMID: 31495542.
75. Chang CC, Wang JL, Wu LC, Chuang LM, Lin HH. Diabetes, Glycemic Control, and Risk of Infection Morbidity and Mortality: A Cohort Study. Open Forum Infectious Diseases. 2019 Oct; Volume 6, Issue 10, ofz358, https://doi.org/10.1093/ofid/ofz358
76. Ng TC, Lo WC, Ku CC, Lu TH, & Lin HH. Improving the use of mortality data in public health: A comparison of garbage code redistribution models. American journal of public health.2020; 110(2), 222-229.
77. Shu CC, Wei YF, Yeh YC, Lin HH, Chen CY, Wang PH, Cheng SL, Wang JY, Yu CJ. The impact on incident tuberculosis by kidney function impairment status: analysis of severity relationship. Respir Res. 2020 Feb 12;21(1):51. doi: 10.1186/s12931-020-1294-5. PMID: 32050967; PMCID: PMC7017479.
78. Fu H, Lin HH, Hallett TB, Arinaminpathy N. Explaining age disparities in tuberculosis burden in Taiwan: a modelling study. BMC Infect Dis. 2020 Mar 4;20(1):191. doi: 10.1186/s12879-020-4914-2. PMID: 32131756; PMCID: PMC7057673.
79. Cheng HY, Jian SW, Liu DP, Ng TC, Huang WT, Lin HH. Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset. JAMA Internal Medicine. 2020;180(9):1156-1163. doi:10.1001/jamainternmed.2020.2020
80. NCD Risk Factor Collaboration (NCD-RisC). Repositioning of the global epicentre of non-optimal cholesterol. Nature. 2020 Jun;582(7810):73-77. doi: 10.1038/s41586-020-2338-1. Epub 2020 Jun 3. PMID: 32494083; PMCID: PMC7332422.
81. Ku CC, Chen CC, Dixon S, Lin HH, Dodd PJ. Patient pathways of tuberculosis care-seeking and treatment: an individual-level analysis of National Health Insurance data in Taiwan. BMJ Glob Health. 2020 Jun;5(6):e002187. doi: 10.1136/bmjgh-2019-002187. PMID: 32565426; PMCID: PMC7307534.
82. NCD Risk Factor Collaboration (NCD-RisC). Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants. Lancet. 2020 Nov 7;396(10261):1511-1524. doi: 10.1016/S0140-6736(20)31859-6. PMID: 33160572; PMCID: PMC7658740.
83. Wu YC, Lo WC, Lu TH, Chang SS, Lin HH, Chan CC. Mortality, morbidity, and risk factors in Taiwan, 1990-2017: findings from the Global Burden of Disease Study 2017. J Formos Med Assoc. 2021 Jun;120(6):1340-1349. doi: 10.1016/j.jfma.2020.11.014. Epub 2020 Dec 10. PMID: 33309080.
84. Yang WS, Chang YC, Chang CH, Wu LC, Wang JL, Lin HH. The Association between Body Mass Index and the Risk of Hospitalization and Mortality due to Infection: a prospective cohort study. Open Forum Infectious Diseases. Oct, 2020. Volume 8, Issue 1, ofaa545, https://doi.org/10.1093/ofid/ofaa545
85. NCD Risk Factor Collaboration (NCD-RisC). Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight. Elife. 2021 Mar 9;10:e60060. doi: 10.7554/eLife.60060. PMID: 33685583; PMCID: PMC7943191.
86. Shen BJ, Lo WC, Lin HH. Global burden of tuberculosis attributable to cancer in 2019: Global, regional, and national estimates. J Microbiol Immunol Infect. 2021 Mar 8:S1684-1182(21)00048-7. doi: 10.1016/j.jmii.2021.02.005. Epub ahead of print. PMID: 33789827.
87. Cheng HY, Cohen T, Lin HH. Test, trace, and isolate in the UK. BMJ. 2021 Mar 31;372:n822. doi: 10.1136/bmj.n822. PMID: 33789886.
88. Ng TC, Cheng HY, Chang HH, Liu CC, Yang CC, Jian SW, Liu DP, Cohen T, Lin HH. Comparison of Estimated Effectiveness of Case-Based and Population-Based Interventions on COVID-19 Containment in Taiwan. JAMA Intern Med. Published online April 06, 2021. doi:10.1001/jamainternmed.2021.1644
89. Summers J, Cheng HY, Lin HH, Barnard LT, Kvalsvig A, Wilson N, Baker MG. Potential lessons from the Taiwan and New Zealand health responses to the COVID-19 pandemic. Lancet Reg Health West Pac. 2020 Nov;4:100044. doi: 10.1016/j.lanwpc.2020.100044. Epub 2020 Oct 21. PMID: 34013216; PMCID: PMC7577184.
90. Shen BJ, Lin HH. Time-dependent association between cancer and risk of tuberculosis: A population-based cohort study. Int J Infect Dis. 2021 Jul;108:340-346. doi: 10.1016/j.ijid.2021.05.037. Epub 2021 May 19. PMID: 34022337.
-Conference abstracts
1. Lin HH, Ezzati M, Murray M. 2006 Nov. Tobacco smoke, indoor air pollution and tuberculosis: A systematic review and meta-analysis. Oral presentation at the 37th Union World Conference at Paris, France. (abstract)
2. Lin HH, Murray M, Cohen T, Colijn C, Ezzati M . 2007 Nov. Modeling the Impacts of Smoking and Solid Fuel Use Interventions on Lung Diseases in China. Oral presentation at the 38th Union World Conference at Cape Town, South Africa. (abstract)
3. Lin HH, Jeon C, Paciorek C, Ezzati M, Murray M. 2008 Oct. Estimating the effect of DOTS in China: a spatial analytic approach. Poster presentation at the 39th Union World Conference at Paris, France. (abstract)
4. Lin HH, Ezzati M, Chang HY, Murray M. 2009 Dec. Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Oral presentation at the 40th Union World Conference at Cancun, Mexico. (abstract)
5. Lin HH, Shin S, Blaya JA, et al. 2010 Nov. Spatiotemporal analysis of drug-susceptible and drug-resistant tuberculosis in Lima, Peru. Poster presentation at the 41st Union World Conference at Berlin, Germany. (abstract)
6. Lee PH, Lin HC, Huang A, Chan PC, Wei SH, Chen CH, Lai MS, Lin HH. 2012 Nov. Diabetes mellitus and risk of recurrent TB: a population-based casecontrol study. Poster presentation at 43th Union World Conference, Kuala Lumpur, Malaysia. (abstract)
7. Lin HH, Chiang YT, Chiang HY. 2012 Nov. Exposure to secondhand smoke and risk of active tuberculosis: prospective cohort study. Oral presentation at 43th Union World Conference, Kuala Lumpur, Malaysia. (abstract)
8. Fu H, Chiang YT, Chang HY, Lin HH. 2013 Apr. Association between body mass index and tuberculosis: prospective cohort study. Poster presentation at The 4th Union Asia-Pacific Region Conference, Hanoi, Vietnam. (abstract)
9. Lai TC, Chan CC, Lin HH. 2013 Oct. Association between ambient air pollution and tuberculosis: prospective cohort study. Oral presentation at the 2013 TPHA&TEA&TIPSPA&TSCR&TSIEQ United Conference, Taipei, Taiwan. (abstract)
10. Lai TC, Chan CC, Lin HH. 2013 Nov. Association between ambient air pollution and tuberculosis: prospective cohort study. Oral presentation at the 44th Union World Conference at Paris, France. (abstract)
11. Pan SC, Chiang YT, Chen CC, Lin HH. 2013 Nov. Investigating the impact of health care visits on incident tuberculosis in Taiwan: population-based study. Oral presentation at the 44th Union World Conference at Paris, France. (abstract)
12. Lin HH, Suk CW, Lo HL, Huang RY, Chiang CY. 2013 Nov. Indoor air pollution from solid fuel and tuberculosis: an updated systematic review and meta-analysis. Poster presentation at the 44th Union World Conference at Paris, France. (abstract)
13. Fu H, Lin HH. 2014 Oct. Modeling the tuberculosis epidemic in Taiwan: the importance of age-dependent reactivation rates. Oral presentation at the 45th Union World Conference at Barcelona, Spain. (abstract)
14. Pan SC, Ku CC, Fang CT, Lin HH. 2014 Oct. The impact of diabetes on the control of tuberculosis in high tuberculosis burden countries. Oral presentation at the 45th Union World Conference at Barcelona, Spain. (abstract)
15. Lo WC, Pan SC, Fu H, Lin HH. 2015 Dec. CD4 count and risk of incident tuberculosis in HIV-infected individuals: a dose-response meta-analysis. Oral presentation at the 46th Union World Conference at Cape Town, South Africa. (abstract)
16. Fu H, Lin HH. 2015 Dec. Body mass index and risk of tuberculosis: analysis from two prospective cohorts. Poster presentation at the 46th Union World Conference at Cape Town, South Africa. (abstract)
17. Lee PH, Fu H, Lai T, Lin HH. 2015 Dec. Glycemic control and risk of tuberculosis among diabetic patients: a cohort study. Oral presentation at the 46th Union World Conference at Cape Town, South Africa. (abstract)
18. Shih YJ, Lin HH. 2015 Dec. Assessment of risk and benefit of BCG vaccine program in Taiwan. Poster presentation at the 46th Union World Conference at Cape Town, South Africa. (abstract)
19. Van Wyk S, Lin HH, Claassens M. 2015 Dec. A systematic review of prediction models for estimating the probability of pulmonary tuberculosis in adults. Poster presentation at the 46th Union World Conference at Cape Town, South Africa. (abstract)
20. Cho P, Wu MY, Wu CY, Shih YJ, Chan CC, Lin HH. 2016 Oct. Chronic kidney disease progression and risk of tuberculosis: a cohort study. Oral presentation at the 47th Union World Conference at Liverpool, United Kingdom. (abstract)
21. Wang CH, Lin HH. 2016 Oct. The effect of risk factor control on tuberculosis in Taiwan: a modelling study. Oral presentation at the 47th Union World Conference at Liverpool, United Kingdom. (abstract)
22. Chu PW, Lin HH. 2017 Oct. Use of metformin and risk of tuberculosis among incident diabetic patients: a population-based study. Oral presentation at the 48th Union World Conference at Guadalajara, Mexico. (abstract)
23. Lin HH, Wu CY, Wang CH, Fu H, Lonnroth K, Chang YC, Huang YT. 2017 Oct. Obesity, diabetes and risk of tuberculosis in two Taiwan cohorts: a double-edged sword?. Short oral presentation at the 48th Union World Conference at Guadalajara, Mexico. (abstract)
24. Lo WC, Wang CH, Lin HH. 2017 Oct. Joint impact of modifiable risk factors on tuberculosis: a population-based cohort study. Short oral presentation at the 48th Union World Conference at Guadalajara, Mexico. (abstract)
25. Ko TH, Lin HH. 2017 Oct. Association between prediabetes and tuberculosis: a cohort study. Poster presentation at the 48th Union World Conference at Guadalajara, Mexico. (abstract)
26. Onyoh E, Kuaban C, Lin HH. 2017 Oct. Pre-treatment loss to follow-up among smear-positive pulmonary tuberculosis patients in Cameroon. Poster presentation at the 48th Union World Conference at Guadalajara, Mexico. (abstract)
27. Ku CC, Chen CC, Dixon S, Lin HH, Dodd PJ. 2018 Oct. Patient health care system interactions before and after tuberculosis diagnosis in Taiwan: and individual patient pathway analysis using health insurance data. Poster presentation at the 49th Union World Conference at The Hague, The Netherlands. (abstract)
28. Fu H, Lin HH, Hallett TB, Arinaminpathy. 2018 Oct. Discontinuing universal bacille Calmette-Guerin vaccination in Taiwan: a dynamic modelling study. Oral presentation at the 49th Union World Conference at The Hague, The Netherlands. (abstract)
29. Ku CC, Chen CC, Dixon S, Lin HH, Dodd PJ. 2018 Oct. Socioeconomic determinants and economic outcomes for tuberculosis patients in Taiwan: an individual patient pathway analysis using health insurance data. Short oral presentation at the 49th Union World Conference at The Hague, The Netherlands. (abstract)
30. ShihYJ, Ayles H, Claassens M, Lin HH. 2018 Oct. Prediction model of active TB in HIV-negative/unknown individuals: development, validation and cost-effectiveness analysis. Poster presentation at the 49th Union World Conference at The Hague, The Netherlands. (abstract)
31. Wu CY, Ezzati, Lonnroth K, Lin HH. 2019 Oct. Impact of nutrition transition and ending hunger on the control of tuberculosis in high tuberculosis-burden countries. Oral presentation at the 50th Union World Conference at Hyderabad, India. (abstract)
32. Tseng HK, Chu PW, Liu KY, Yang SL, Chiang CY, Chang HY, Chen B, Lo HY, Huang YF, Lin HH. 2019 Oct. National tuberculosis patient cost survey in Taiwan: design, implementation, and preliminary. Short oral presentation at the 50th Union World Conference at Hyderabad, India. (abstract)
33. Yang CC, Shih YJ, Ayles H, Godfrey-Faussett P, Claassens M, Lin HH. 2019 Oct. Development and validation of a prediction model for systematic screening of active tuberculosis among people living with HIV. E-poster presentation at the 50th Union World Conference at Hyderabad, India. (abstract)
34. Onyoh E, Wu CY, Lin HH. 2019 Nov. Impact of tuberculosis patient counselling and phone reminders on reducing pre-treatment loss to follow-up: a before-and-after study in Cameroon. Poster presentation at the 50th Union World Conference at Hyderabad, India. (abstract)
2. Lin HH, Murray M, Cohen T, Colijn C, Ezzati M . 2007 Nov. Modeling the Impacts of Smoking and Solid Fuel Use Interventions on Lung Diseases in China. Oral presentation at the 38th Union World Conference at Cape Town, South Africa. (abstract)
3. Lin HH, Jeon C, Paciorek C, Ezzati M, Murray M. 2008 Oct. Estimating the effect of DOTS in China: a spatial analytic approach. Poster presentation at the 39th Union World Conference at Paris, France. (abstract)
4. Lin HH, Ezzati M, Chang HY, Murray M. 2009 Dec. Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Oral presentation at the 40th Union World Conference at Cancun, Mexico. (abstract)
5. Lin HH, Shin S, Blaya JA, et al. 2010 Nov. Spatiotemporal analysis of drug-susceptible and drug-resistant tuberculosis in Lima, Peru. Poster presentation at the 41st Union World Conference at Berlin, Germany. (abstract)
6. Lee PH, Lin HC, Huang A, Chan PC, Wei SH, Chen CH, Lai MS, Lin HH. 2012 Nov. Diabetes mellitus and risk of recurrent TB: a population-based casecontrol study. Poster presentation at 43th Union World Conference, Kuala Lumpur, Malaysia. (abstract)
7. Lin HH, Chiang YT, Chiang HY. 2012 Nov. Exposure to secondhand smoke and risk of active tuberculosis: prospective cohort study. Oral presentation at 43th Union World Conference, Kuala Lumpur, Malaysia. (abstract)
8. Fu H, Chiang YT, Chang HY, Lin HH. 2013 Apr. Association between body mass index and tuberculosis: prospective cohort study. Poster presentation at The 4th Union Asia-Pacific Region Conference, Hanoi, Vietnam. (abstract)
9. Lai TC, Chan CC, Lin HH. 2013 Oct. Association between ambient air pollution and tuberculosis: prospective cohort study. Oral presentation at the 2013 TPHA&TEA&TIPSPA&TSCR&TSIEQ United Conference, Taipei, Taiwan. (abstract)
10. Lai TC, Chan CC, Lin HH. 2013 Nov. Association between ambient air pollution and tuberculosis: prospective cohort study. Oral presentation at the 44th Union World Conference at Paris, France. (abstract)
11. Pan SC, Chiang YT, Chen CC, Lin HH. 2013 Nov. Investigating the impact of health care visits on incident tuberculosis in Taiwan: population-based study. Oral presentation at the 44th Union World Conference at Paris, France. (abstract)
12. Lin HH, Suk CW, Lo HL, Huang RY, Chiang CY. 2013 Nov. Indoor air pollution from solid fuel and tuberculosis: an updated systematic review and meta-analysis. Poster presentation at the 44th Union World Conference at Paris, France. (abstract)
13. Fu H, Lin HH. 2014 Oct. Modeling the tuberculosis epidemic in Taiwan: the importance of age-dependent reactivation rates. Oral presentation at the 45th Union World Conference at Barcelona, Spain. (abstract)
14. Pan SC, Ku CC, Fang CT, Lin HH. 2014 Oct. The impact of diabetes on the control of tuberculosis in high tuberculosis burden countries. Oral presentation at the 45th Union World Conference at Barcelona, Spain. (abstract)
15. Lo WC, Pan SC, Fu H, Lin HH. 2015 Dec. CD4 count and risk of incident tuberculosis in HIV-infected individuals: a dose-response meta-analysis. Oral presentation at the 46th Union World Conference at Cape Town, South Africa. (abstract)
16. Fu H, Lin HH. 2015 Dec. Body mass index and risk of tuberculosis: analysis from two prospective cohorts. Poster presentation at the 46th Union World Conference at Cape Town, South Africa. (abstract)
17. Lee PH, Fu H, Lai T, Lin HH. 2015 Dec. Glycemic control and risk of tuberculosis among diabetic patients: a cohort study. Oral presentation at the 46th Union World Conference at Cape Town, South Africa. (abstract)
18. Shih YJ, Lin HH. 2015 Dec. Assessment of risk and benefit of BCG vaccine program in Taiwan. Poster presentation at the 46th Union World Conference at Cape Town, South Africa. (abstract)
19. Van Wyk S, Lin HH, Claassens M. 2015 Dec. A systematic review of prediction models for estimating the probability of pulmonary tuberculosis in adults. Poster presentation at the 46th Union World Conference at Cape Town, South Africa. (abstract)
20. Cho P, Wu MY, Wu CY, Shih YJ, Chan CC, Lin HH. 2016 Oct. Chronic kidney disease progression and risk of tuberculosis: a cohort study. Oral presentation at the 47th Union World Conference at Liverpool, United Kingdom. (abstract)
21. Wang CH, Lin HH. 2016 Oct. The effect of risk factor control on tuberculosis in Taiwan: a modelling study. Oral presentation at the 47th Union World Conference at Liverpool, United Kingdom. (abstract)
22. Chu PW, Lin HH. 2017 Oct. Use of metformin and risk of tuberculosis among incident diabetic patients: a population-based study. Oral presentation at the 48th Union World Conference at Guadalajara, Mexico. (abstract)
23. Lin HH, Wu CY, Wang CH, Fu H, Lonnroth K, Chang YC, Huang YT. 2017 Oct. Obesity, diabetes and risk of tuberculosis in two Taiwan cohorts: a double-edged sword?. Short oral presentation at the 48th Union World Conference at Guadalajara, Mexico. (abstract)
24. Lo WC, Wang CH, Lin HH. 2017 Oct. Joint impact of modifiable risk factors on tuberculosis: a population-based cohort study. Short oral presentation at the 48th Union World Conference at Guadalajara, Mexico. (abstract)
25. Ko TH, Lin HH. 2017 Oct. Association between prediabetes and tuberculosis: a cohort study. Poster presentation at the 48th Union World Conference at Guadalajara, Mexico. (abstract)
26. Onyoh E, Kuaban C, Lin HH. 2017 Oct. Pre-treatment loss to follow-up among smear-positive pulmonary tuberculosis patients in Cameroon. Poster presentation at the 48th Union World Conference at Guadalajara, Mexico. (abstract)
27. Ku CC, Chen CC, Dixon S, Lin HH, Dodd PJ. 2018 Oct. Patient health care system interactions before and after tuberculosis diagnosis in Taiwan: and individual patient pathway analysis using health insurance data. Poster presentation at the 49th Union World Conference at The Hague, The Netherlands. (abstract)
28. Fu H, Lin HH, Hallett TB, Arinaminpathy. 2018 Oct. Discontinuing universal bacille Calmette-Guerin vaccination in Taiwan: a dynamic modelling study. Oral presentation at the 49th Union World Conference at The Hague, The Netherlands. (abstract)
29. Ku CC, Chen CC, Dixon S, Lin HH, Dodd PJ. 2018 Oct. Socioeconomic determinants and economic outcomes for tuberculosis patients in Taiwan: an individual patient pathway analysis using health insurance data. Short oral presentation at the 49th Union World Conference at The Hague, The Netherlands. (abstract)
30. ShihYJ, Ayles H, Claassens M, Lin HH. 2018 Oct. Prediction model of active TB in HIV-negative/unknown individuals: development, validation and cost-effectiveness analysis. Poster presentation at the 49th Union World Conference at The Hague, The Netherlands. (abstract)
31. Wu CY, Ezzati, Lonnroth K, Lin HH. 2019 Oct. Impact of nutrition transition and ending hunger on the control of tuberculosis in high tuberculosis-burden countries. Oral presentation at the 50th Union World Conference at Hyderabad, India. (abstract)
32. Tseng HK, Chu PW, Liu KY, Yang SL, Chiang CY, Chang HY, Chen B, Lo HY, Huang YF, Lin HH. 2019 Oct. National tuberculosis patient cost survey in Taiwan: design, implementation, and preliminary. Short oral presentation at the 50th Union World Conference at Hyderabad, India. (abstract)
33. Yang CC, Shih YJ, Ayles H, Godfrey-Faussett P, Claassens M, Lin HH. 2019 Oct. Development and validation of a prediction model for systematic screening of active tuberculosis among people living with HIV. E-poster presentation at the 50th Union World Conference at Hyderabad, India. (abstract)
34. Onyoh E, Wu CY, Lin HH. 2019 Nov. Impact of tuberculosis patient counselling and phone reminders on reducing pre-treatment loss to follow-up: a before-and-after study in Cameroon. Poster presentation at the 50th Union World Conference at Hyderabad, India. (abstract)
-Book chapter
1. Chiang Chen-Yuan, Sven Gudmund Hinderaker, Lin Hsien-Ho, Donald A. Enarson. Springer Publisher. Handbook of Global Tuberculosis Control: Practices & Challenges. Chapter “Latent Infection with Mycobacterium tuberculosis”.
2. 林先和：結核病與全球衛生威脅。國際衛生，張武修主編 (2012)。 台北：華杏出版股份有限公司；287-311頁。
2. 林先和：結核病與全球衛生威脅。國際衛生，張武修主編 (2012)。 台北：華杏出版股份有限公司；287-311頁。
